Last reviewed · How we verify
WCK 2349 Oral
WCK 2349 Oral is a Small molecule drug developed by Wockhardt. It is currently in Phase 1 development. Also known as: levonadifloxacin (active drug).
At a glance
| Generic name | WCK 2349 Oral |
|---|---|
| Also known as | levonadifloxacin (active drug) |
| Sponsor | Wockhardt |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349 (PHASE1)
- Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers (PHASE1)
- Pharmacokinetics of WCK 2349 In Patients With Hepatic Impairment (PHASE1)
- Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects (PHASE1)
- Phase I, Open Label,Crossover Food-Effect and Absolute Bioavailability Study of WCK2349 and WCK771 in Healthy Adult Human Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- WCK 2349 Oral CI brief — competitive landscape report
- WCK 2349 Oral updates RSS · CI watch RSS
- Wockhardt portfolio CI
Frequently asked questions about WCK 2349 Oral
What is WCK 2349 Oral?
WCK 2349 Oral is a Small molecule drug developed by Wockhardt.
Who makes WCK 2349 Oral?
WCK 2349 Oral is developed by Wockhardt (see full Wockhardt pipeline at /company/wockhardt).
Is WCK 2349 Oral also known as anything else?
WCK 2349 Oral is also known as levonadifloxacin (active drug).
What development phase is WCK 2349 Oral in?
WCK 2349 Oral is in Phase 1.
Related
- Manufacturer: Wockhardt — full pipeline
- Also known as: levonadifloxacin (active drug)
- Compare: WCK 2349 Oral vs similar drugs
- Pricing: WCK 2349 Oral cost, discount & access